ZMYM3 May Promote Cell Proliferation in Small Cell Lung Carcinoma.
ZMYM3
cell proliferation
immunohistochemistry
lung carcinoma
mouse tissues
Journal
Acta histochemica et cytochemica
ISSN: 0044-5991
Titre abrégé: Acta Histochem Cytochem
Pays: Japan
ID NLM: 0147110
Informations de publication
Date de publication:
29 Oct 2021
29 Oct 2021
Historique:
received:
19
01
2021
accepted:
16
08
2021
entrez:
12
11
2021
pubmed:
13
11
2021
medline:
13
11
2021
Statut:
ppublish
Résumé
Zinc finger, myeloproliferative, and mental retardation-type containing 3 (ZMYM3) is a highly conserved protein among vertebrates. Although it promotes DNA repair and moderate histone acetylation, the other functions of ZMYM3 remain unclear. We herein examined the physiological functions of ZMYM3 in human lung cancer using a
Identifiants
pubmed: 34764523
doi: 10.1267/ahc.21-00012
pii: JST.JSTAGE/ahc/21-00012
pmc: PMC8569135
doi:
Types de publication
Journal Article
Langues
eng
Pagination
143-153Informations de copyright
2021 The Japan Society of Histochemistry and Cytochemistry.
Déclaration de conflit d'intérêts
VThe authors declare that there are no conflicts of interest.
Références
J Immunol Methods. 1991 Jun 3;139(2):271-9
pubmed: 1710634
J Affect Disord. 2019 May 15;251:86-90
pubmed: 30909162
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Nature. 2012 Aug 2;488(7409):43-8
pubmed: 22722829
Genomics. 2000 Jan 1;63(1):123-32
pubmed: 10662551
Mol Cancer Res. 2012 Mar;10(3):469-82
pubmed: 22232518
Nature. 2015 Aug 6;524(7563):47-53
pubmed: 26168399
Cancer Res. 1987 May 15;47(10):2594-8
pubmed: 2436751
Cell. 2015 Nov 5;163(4):1011-25
pubmed: 26544944
Gene. 2015 Sep 10;569(1):88-94
pubmed: 26022613
J Immunol. 1978 Dec;121(6):2228-34
pubmed: 102692
J Cell Biol. 1986 Dec;103(6 Pt 2):2569-81
pubmed: 3025219
J Cell Biochem Suppl. 1996;24:210-7
pubmed: 8806103
N Engl J Med. 2011 Dec 29;365(26):2497-506
pubmed: 22150006
J Biol Chem. 2003 Feb 28;278(9):7234-9
pubmed: 12493763
Int J Cancer. 1997 Apr 22;74(2):180-4
pubmed: 9133452
Cytopathology. 2019 Mar;30(2):194-200
pubmed: 30290028
Blood. 1994 Sep 1;84(5):1415-20
pubmed: 8068938
Genes Dev. 1993 May;7(5):812-21
pubmed: 8491378
Int J Cancer. 2009 Apr 15;124(8):1778-84
pubmed: 19117057
Cancer Res. 1990 Sep 1;50(17):5481-7
pubmed: 2386953
Genes Dev. 2017 Feb 1;31(3):260-274
pubmed: 28242625
Lab Invest. 1998 Jan;78(1):73-8
pubmed: 9461123
Orphanet J Rare Dis. 2014 Apr 11;9:49
pubmed: 24721225
Cancer Res. 1980 Oct;40(10):3502-7
pubmed: 6108156
Acta Histochem Cytochem. 2018 Feb 27;51(1):53-62
pubmed: 29622850
J Cell Mol Med. 2014 Jun;18(6):1004-17
pubmed: 24571310
J Natl Cancer Inst. 1973 Nov;51(5):1417-23
pubmed: 4357758
Cancer Res. 2000 Sep 1;60(17):4894-906
pubmed: 10987304
Nat Rev Clin Oncol. 2020 May;17(5):300-312
pubmed: 32055013
PLoS One. 2015 Mar 17;10(3):e0120352
pubmed: 25781952
Cell Death Dis. 2017 Jun 29;8(6):e2910
pubmed: 28661483
Int J Cancer. 1983 Jan 15;31(1):13-20
pubmed: 6339421
Clin Epigenetics. 2016 Aug 31;8:88
pubmed: 27588146
Hum Mol Genet. 1996 Jul;5(7):887-97
pubmed: 8817323
J Thorac Oncol. 2015 Sep;10(9):1240-1242
pubmed: 26291007
Exp Gerontol. 1998 Sep;33(6):525-33
pubmed: 9789730
Lung. 2020 Dec;198(6):897-907
pubmed: 33175991
Cancer Discov. 2014 Nov;4(11):1342-53
pubmed: 25223734
Cancer Chemother Pharmacol. 1994;33(5):385-90
pubmed: 8306412
Blood. 1994 Mar 1;83(5):1268-77
pubmed: 7509654
Mol Genet Genomics. 2018 Jun;293(3):747-752
pubmed: 29332164
Acta Histochem Cytochem. 2019 Jun 25;52(3):45-58
pubmed: 31341340